Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
Open Access
- 1 September 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (39), 34457-34467
- https://doi.org/10.1074/jbc.m111.229633
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse ModelJournal of Neuroscience, 2010
- Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial ActivationJournal of Neuroscience, 2003
- Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubilityJournal of Neurochemistry, 2002
- Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau ProteinJournal of Neuroscience, 2002
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Alzheimer-Related τ-Pathology in the Perforant Path Target Zone and in the Hippocampal Stratum Oriens and Radiatum Correlates with Onset and Degree of DementiaExperimental Neurology, 2000
- Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205Neuroscience Letters, 1995
- Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404Journal of Neuroscience Research, 1994
- Laboratory Investigation of Cerebrospinal Fluid ProteinsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1990
- A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.Proceedings of the National Academy of Sciences of the United States of America, 1990